Histologic Subtypes of Non-Small Cell Lung Cancer: Can We Further Personalize Radiation Therapy?

[1]  A. Nicholson,et al.  The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015. , 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  V. Verma,et al.  Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy10 enough? , 2019, Lung cancer.

[3]  S. Itasaka,et al.  Non-small cell lung cancer with pathological complete response: predictive factors and surgical outcomes , 2019, General Thoracic and Cardiovascular Surgery.

[4]  J. Galvin,et al.  Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer , 2018, JAMA oncology.

[5]  E. Ziv,et al.  Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma , 2017, CardioVascular and Interventional Radiology.

[6]  P. Xia,et al.  A Histologic Basis for the Efficacy of SBRT to the lung , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  E. Yorke,et al.  Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.

[8]  S. Lu,et al.  Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  M. Okada,et al.  Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma. , 2015, Lung cancer.

[10]  Prasad S Adusumilli,et al.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. , 2013, Journal of the National Cancer Institute.

[11]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.